Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Olsson

Showing results (211-220 of 216) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 216 results.
Journal of Neurology|July 16, 2013
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid usePaul W O'Connor, Fred D Lublin, Jerry S Wolinsky, et al.
Multiple Sclerosis and Related Disorders|September 10, 2020
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension studyAaron E Miller, Tomas P Olsson, Jerry S Wolinsky, et al.
Science (New York, N.Y.)|March 18, 2006
Ecology. Globalization, roving bandits, and marine resourcesF Berkes, T P Hughes, R S Steneck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trialPatrick Vermersch, Anna Czlonkowska, Luigi M E Grimaldi, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|July 30, 2011
Creation of a gilded trap by the high economic value of the Maine lobster fisheryR S Steneck, T P Hughes, J E Cinner, et al.
ESMO Open|June 5, 2024
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)H O Ohnstad, E S Blix, L A Akslen, et al.
Pageof 22

Showing results (211-220 of 216) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 216 results.
Journal of Neurology|July 16, 2013
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid usePaul W O'Connor, Fred D Lublin, Jerry S Wolinsky, et al.
Multiple Sclerosis and Related Disorders|September 10, 2020
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension studyAaron E Miller, Tomas P Olsson, Jerry S Wolinsky, et al.
Science (New York, N.Y.)|March 18, 2006
Ecology. Globalization, roving bandits, and marine resourcesF Berkes, T P Hughes, R S Steneck, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trialPatrick Vermersch, Anna Czlonkowska, Luigi M E Grimaldi, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|July 30, 2011
Creation of a gilded trap by the high economic value of the Maine lobster fisheryR S Steneck, T P Hughes, J E Cinner, et al.
ESMO Open|June 5, 2024
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)H O Ohnstad, E S Blix, L A Akslen, et al.
Pageof 22